General Remarks.
All chemicals and solvents were purchased from commercial suppliers and used without further purification. Synthesis of the compounds wa s performed on Rink Amide MBHA resin purchased from Nova Biochem (San Deigo, CA). Preparative HPLC was performed on a Waters Breeze HPLC system with a Vydac C18 preprative column. Flow rate was 10 ml/min. HPLC runs used linear gradients of 0.1% TFA and 90% acetonitrile plus 0.1% TFA. Mass spectrometry was performed on all synthesized compounds with the MALDI-Vo yager DE Pro instrument.
Synthesis of RIP-1.4 and C2.
After removing the Fmoc protecting group on Rink Amide MBHA resin, the peptoid residues involved in RIP-1.4 and C2 were conjugated using a microwave-assisted protocol in a scale of 0.1 mmol as described previously [S1,S2] . The resulting conjugates were cleaved from the resin by 2 mL of 95% TFA, 2.5% water, and 2.5% triisopropylsilane (cleavage cocktail) at room temperature for 2 h. TFA was removed and the crude product was purified by C18 RP-HPLC. 
Synthesis of purine-deleted compound.
At the end of the peptoid synthesis, Boc-Lys(Fmoc)-OH (Novabiochem) was attached to the N-terminal of the peptoids by standard peptide synthesis using Fmoc chemistry. The
Fmoc protecting group was removed by 20% piperidine in DMF. The resulting compound was cleaved from the resin by 2 mL of the cleavage cocktail at room 
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Synthesis of ICT-deleted compound.
The peptoid residues involved in the ICT-deleted compound and subsequently BocLys(Fmoc)-OH were conjugated as described above. The Fmoc protecting group was removed by 20% piperidine in DMF. The resulting free amine was coupled with 6-(9H-purin-6-ylamino)hexanoic acid as described previously. The resulting conjugate was cleaved from the resin by cleavage cocktail and purified by C18 RP-HP LC. 
Synthesis of glycine-scanned compounds (R1 -R5 ).
Glycine-scanned compounds were synthesized as described above except for the glycine conjugation step. The coupling reaction to the corresponding peptoids was performed with a mixture of Fmoc-Gly-OH (Novabiochem), HBTU and N-methylmorpholine in 
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Scheme S1. Synthesis of R1-deleted compound as a representative of glycine-sc anned compounds.
Synthesis of azide-RIP-1.
Azide-RIP-1 was prepared as described previously for the synthesis of RIP- by immunoaffinity chromatography and FLAG ® peptide (Sigma) elution. To purify the 20S proteasome, the entire procedure described above was carried out in the absence of ATP and 1× ARS (ATP regenerating system).
Peptidase Assay. Th e proteasome peptidase activity was measured using Suc-LLVY- RIP-1.4, DMSO itself and MG132, cells were lysed in 1% SDS/10 mM Tris-HCl, pH 7.5.
Protein concentration was measured using BCA protein assay reagent (Pierce). Equal amount of protein samples (25 µg) were subjected to 10% SDS-PAGE and transferred to a PVDF membrane (Immobilon-P, Millipore). The membranes with transferred proteins were blocked with 1 × TBST containing 5% non-fat, dried milk and then incubated with anti-p27 Kip1 antibody (Cell Signaling) and subsequently secondary antibody labeled with horseradish peroxidase. Signals were visualized by enhanced chemiluminescence detection system (Amersham Pharmacia Biotech).
